|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Shi, Run; Wang, Xin; Wu, Yang; Xu, Bin; Zhao, Tianyu; Trapp, Christian; Wang, Xuanbin; Unger, Kristian; Zhou, Cheng; Lu, Shun; Buchner, Alexander; Schulz, Gerald Bastian; Cao, Fengjun; Belka, Claus; Su, Chuan; Li, Minglun und Shu, Yongqian
(2022):
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
In: Theranostics, Bd. 12, Nr. 9: S. 4181-4199
2021
Wang, Dongpeng; Wang, Xian-He; Yu, Xiongjie; Cao, Fengjun; Cai, Xiaojun; Chen, Ping; Li, Minglun; Feng, Yibin; Li, Hongliang und Wang, Xuanbin
(15. April 2021):
Pharmacokinetics of Anthraquinones from Medicinal Plants.
In: Frontiers in Pharmacology, Bd. 12, 638993
[PDF, 1MB]
2019
Ding, Yan; Liu, Yuechao; Li, Hongliang; Li, Yong; Li, Minglun; Liu, Ming; Wang, Xianhe; Cao, Fengjun und Wang, Xuanbin
(5. September 2019):
Chinese Medicines for Preventing and Treating Radiation-Induced Pulmonary Injury: Still a Long Way to Go.
In: Frontiers in Pharmacology, Bd. 10, 927: S. 1-10
[PDF, 2MB]
Yang, Nian; Li, Chen; Li, Hongliang; Liu, Ming; Cai, Xiaojun; Cao, Fengjun; Feng, Yibin; Li, Minglun und Wang, Xuanbin
(25. Juni 2019):
Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells.
In: Frontiers in Pharmacology, Bd. 10, 709: S. 1-14
[PDF, 15MB]